Analysis and Commentary 5/21/21 Analysis and Commentary 5/21/21 Messaging for Upcoming Senate Hill Days Read More Advocacy at a Glance 5/8/21 Advocacy at a Glance 5/8/21 Hill Days focusing on Senate staff on May 25 and 26. Alliance webinars upcoming with CDER Director Cavazzoni and FDA’s food and animal health leadership. Read More Analysis and Commentary 1/21/21 Analysis and Commentary 1/21/21 Leadership and FDA Appropriation for FY 22 Read More Analysis and Commentary 1/8/21 Analysis and Commentary 1/8/21 Now We Know Who'll Be in Charge Read More Analysis and Commentary 10/16/20 Analysis and Commentary 10/16/20 Future Changes in Congressional Committees and the FDA Read More Analysis and Commentary 8/14/20 Analysis and Commentary 8/14/20 "Somehow the CR Will Pass", But When? Read More Advocacy at a Glance 8/7/20 Advocacy at a Glance 8/7/20 Advocacy at a Glance Read More Advocacy at a Glance 8/1/20 Advocacy at a Glance 8/1/20 Advocacy at a Glance Read More Analysis and Commentary 7/18/20 Analysis and Commentary 7/18/20 Why No Movement in the Senate? Read More Advocacy at a Glance 7/18/20 Advocacy at a Glance 7/18/20 Advocacy at a Glance Read More Advocacy at a Glance 6/5/20 Advocacy at a Glance 6/5/20 Advocacy at a Glance Read More 11/21/19 11/21/19 Senate HELP Committee Interviews Stephen Hahn, MD Read More Analysis and Commentary 9/20/19 Analysis and Commentary 9/20/19 More Questions and More Answers ... Once Again Read More Advocacy at a Glance 9/20/19 Advocacy at a Glance 9/20/19 Advocacy at a Glance Read More Analysis and Commentary 9/13/19 Analysis and Commentary 9/13/19 CR-Level Funding at Start of FY 20 Approaches Certainty Read More Analysis and Commentary 8/23/19 Analysis and Commentary 8/23/19 Sometimes Things Just Don't Go as Planned (or Hoped) Read More Analysis and Commentary 11/2/18 Analysis and Commentary 11/2/18 Changes Are Inevitable. Some Predictable; Others Not Read More 9/7/18 9/7/18 Timing, Knowns, and Unknowns: FDA's FY 19 Appropriation Read More Analysis and Commentary 8/31/18 Analysis and Commentary 8/31/18 On the Physical Capabilities of a Lame Duck Read More Analysis and Commentary 5/24/18 Analysis and Commentary 5/24/18 FY 19 Funding: House and Senate Proposals Read More Older Posts
Analysis and Commentary 5/21/21 Analysis and Commentary 5/21/21 Messaging for Upcoming Senate Hill Days Read More
Advocacy at a Glance 5/8/21 Advocacy at a Glance 5/8/21 Hill Days focusing on Senate staff on May 25 and 26. Alliance webinars upcoming with CDER Director Cavazzoni and FDA’s food and animal health leadership. Read More
Analysis and Commentary 1/21/21 Analysis and Commentary 1/21/21 Leadership and FDA Appropriation for FY 22 Read More
Analysis and Commentary 1/8/21 Analysis and Commentary 1/8/21 Now We Know Who'll Be in Charge Read More
Analysis and Commentary 10/16/20 Analysis and Commentary 10/16/20 Future Changes in Congressional Committees and the FDA Read More
Analysis and Commentary 8/14/20 Analysis and Commentary 8/14/20 "Somehow the CR Will Pass", But When? Read More
Analysis and Commentary 7/18/20 Analysis and Commentary 7/18/20 Why No Movement in the Senate? Read More
Analysis and Commentary 9/20/19 Analysis and Commentary 9/20/19 More Questions and More Answers ... Once Again Read More
Analysis and Commentary 9/13/19 Analysis and Commentary 9/13/19 CR-Level Funding at Start of FY 20 Approaches Certainty Read More
Analysis and Commentary 8/23/19 Analysis and Commentary 8/23/19 Sometimes Things Just Don't Go as Planned (or Hoped) Read More
Analysis and Commentary 11/2/18 Analysis and Commentary 11/2/18 Changes Are Inevitable. Some Predictable; Others Not Read More
Analysis and Commentary 8/31/18 Analysis and Commentary 8/31/18 On the Physical Capabilities of a Lame Duck Read More
Analysis and Commentary 5/24/18 Analysis and Commentary 5/24/18 FY 19 Funding: House and Senate Proposals Read More
